Login / Signup

Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy.

Samir KhandhadiaSuresh ThulasidharanNguyen Thuy Vy HoangSameh Alkhalili IbrahimYanling OuyangAndrew John Lotery
Published in: Eye (London, England) (2022)
We found overall a mean improvement in VA and structural outcomes after PDT. In the absence of randomised clinical trials this study supports the use of half dose PDT for treatment of chronic CSCR.
Keyphrases
  • photodynamic therapy
  • clinical trial
  • fluorescence imaging
  • high grade
  • open label
  • randomized controlled trial
  • type diabetes
  • drug induced
  • metabolic syndrome
  • insulin resistance